Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Int J Cancer
    September 2022
  1. KAHESA C, Thomsen LT, Linde DS, Mchome B, et al
    Comparison of human papillomavirus (HPV)-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Int J Cancer. 2022 Sep 12. doi: 10.1002/ijc.34283.
    >> Share

    August 2022
  2. DESHMUKH AA, Damgacioglu H, Georges D, Sonawane K, et al
    Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: a worldwide analysis.
    Int J Cancer. 2022 Aug 28. doi: 10.1002/ijc.34269.
    >> Share

  3. RASHIDIAN H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, et al
    Opium use and risk of lung cancer: A multicenter case-control study in Iran.
    Int J Cancer. 2022 Aug 13. doi: 10.1002/ijc.34244.
    >> Share

  4. SENGAYI-MUCHENGETI M, Singh E, Chen WC, Bradshaw D, et al
    Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016).
    Int J Cancer. 2022 Aug 4. doi: 10.1002/ijc.34236.
    >> Share

    July 2022
  5. JOSHI S, Muwonge R, Kulkarni V, Mandolkar M, et al
    Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India.
    Int J Cancer. 2022 Jul 19. doi: 10.1002/ijc.34221.
    >> Share

  6. CLARKE MA, Deshmukh AA, Suk R, Roberts J, et al
    A Systematic Review and Meta-Analysis of Cytology and HPV-related Biomarkers for Anal Cancer Screening Among Different Risk Groups.
    Int J Cancer. 2022 Jul 6. doi: 10.1002/ijc.34199.
    >> Share

    June 2022
  7. MOLEBATSI K, Iyer HS, Kohler RE, Gabegwe K, et al
    Improving identification of symptomatic cancer at primary care clinics: A predictive modeling analysis in Botswana.
    Int J Cancer. 2022 Jun 18. doi: 10.1002/ijc.34178.
    >> Share

  8. FABER MT, Frederiksen K, Palefsky JM, Kjaer SK, et al
    A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer.
    Int J Cancer. 2022 Jun 3. doi: 10.1002/ijc.34143.
    >> Share

    February 2022
  9. AYENI OA, O'Neil DS, Pumpalova YS, Chen WC, et al
    Impact of HIV infection on Survival among Women with Stage I-III Breast Cancer: Results from the South African Breast Cancer and HIV Outcomes Study.
    Int J Cancer. 2022 Feb 26. doi: 10.1002/ijc.33981.
    >> Share

    January 2022
  10. IBRAHIM KHALIL A, Franceschi S, de Martel C, Bray F, et al
    Burden of Kaposi sarcoma according to HIV status: a systematic review and global analysis.
    Int J Cancer. 2022 Jan 27. doi: 10.1002/ijc.33951.
    >> Share

    October 2021
  11. IBRAHIM KHALIL A, Mpunga T, Wei F, Baussano I, et al
    Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33841.
    >> Share

  12. MPUNGA T, Clifford GM, Morgan EA, Milner DA Jr, et al
    Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33840.
    >> Share

    July 2021
  13. VAN DER ZEE RP, Meijer CJLM, Cuming T, Kreuter A, et al
    Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men by immunohistochemical markers p16, Ki-67, HPV-E4, and DNA methylation markers.
    Int J Cancer. 2021 Jul 26. doi: 10.1002/ijc.33748.
    >> Share

    June 2021
  14. VAN SCHALKWYK C, Moodley J, Welte A, Johnson LF, et al
    Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
    Int J Cancer. 2021 Jun 24. doi: 10.1002/ijc.33716.
    >> Share

  15. YEKEDUZ E, Trapani D, Xu W, de Vries EG, et al
    Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors.
    Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33708.
    >> Share

  16. JAQUET A, Boni SP, Boidy K, Tine J, et al
    Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
    Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33709.
    >> Share

    May 2021
  17. STOETER O, Seraphin TP, Chitsike I, Chokunonga E, et al
    Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda).
    Int J Cancer. 2021 May 4. doi: 10.1002/ijc.33619.
    >> Share

    March 2021
  18. CHINULA L, Topazian HM, Mapanje C, Varela A, et al
    Uptake and safety of community-based 'screen-and-treat' with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Int J Cancer. 2021 Mar 9. doi: 10.1002/ijc.33549.
    >> Share

    February 2021
  19. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    >> Share

  20. HALL MT, Smith MA, Simms KT, Barnabas R, et al
    Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33533.
    >> Share

    November 2020
  21. AYENI OA, Norris SA, Joffe M, Cubasch H, et al
    Pre-existing morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African Breast Cancer-Disparities in Outcomes (ABC-DO) study.
    Int J Cancer. 2020 Nov 12. doi: 10.1002/ijc.33387.
    >> Share

    October 2020
  22. BUKIRWA P, Wabinga H, Nambooze S, Amulen PM, et al
    Trends in the incidence of cancer in Kampala, Uganda 1991-2015.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33373.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016